Modus Therapeutics AB
Modus (previously known as Dilaforette) is a Swedish drug development company developing sevuparin, an innovative, proprietary polysaccharide drug, which has potential to restore blood flow and preven...load more
Modus Therapeutics AB's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Sweden
Website
Founded Year
2011
Headcount
2 - 10 ( View All )
Modus Therapeutics AB's Competitors
Professional Pharmacy
View all employeesDAK Pharmaceuticals
View all employeesTAS Polymers
View all employeesEmployee Insights
Frequently Asked Questions Regarding Modus Therapeutics AB
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts